文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

处方医生退出劳动力市场导致长期阿片类药物治疗中止后的临床与医疗使用结局:准实验双重差分研究

Clinical and healthcare use outcomes after cessation of long term opioid treatment due to prescriber workforce exit: quasi-experimental difference-in-differences study.
PubMed 文献 · BMJ · 2024-05-16
一句话结论处方医生退出劳动力市场后,长期阿片类治疗中止率上升,自杀未遂、阿片或酒精戒断及住院/急诊就诊出现一过性升高,过量无显著变化。

该准实验双重差分研究基于2011-18年美国Medicare受益人20%样本,纳入因处方医生退出劳动力市场(如退休或死亡)而失去长期阿片类治疗处方医生的患者48079例,并按倾向性评分匹配48079例处方医生未退出的长期阿片类治疗患者。长期阿片类治疗定义为连续四个季度每季度至少60天阿片类处方,归属于主要阿片类处方医生。结果显示,处方医生退出后一个季度,长期阿片类治疗中止率从每万患者132例升至229例,而对照组从97例升至100例(校正差值1.22个百分点,95%CI 1.02至1.42)。退出后第一季度,自杀未遂(校正差值0.05个百分点,95%CI 0.01至0.09)、阿片或酒精戒断(0.14,95%CI 0.01至0.27)及住院或急诊就诊(0.04次就诊,95%CI 0.01至0.06)出现一过性显著升高,这些差异在1至2个季度后消退;过量无显著变化。退出后四个季度整体,精神卫生危机(0.39个百分点,95%CI 0.08至0.69)和阿片或酒精戒断(0.31,95%CI 0.014至0.58)升高,药物过量无变化(-0.12,95%CI -0.41至0.18)。结论认为,处方医生流失与长期阿片类治疗中止及自杀未遂等不良结局的一过性增加相关,但未涉及过量等其他结局;在考虑未观察混杂后,长期阿片类治疗中止可能与暂时性健康不良影响相关。

要点

  • 处方医生退出后一季度,长期阿片类治疗中止率从每万患者132例升至229例,对照组从97例升至100例(校正差值1.22个百分点,95%CI 1.02至1.42)。
  • 退出后第一季度自杀未遂校正差值0.05个百分点(95%CI 0.01至0.09),阿片或酒精戒断0.14(95%CI 0.01至0.27),住院或急诊就诊0.04次(95%CI 0.01至0.06),1至2个季度后消退。
  • 退出后四个季度整体,精神卫生危机升高0.39个百分点(95%CI 0.08至0.69),阿片或酒精戒断升高0.31(95%CI 0.014至0.58)。
  • 药物过量在退出后第一季度及四个季度整体均无显著变化(整体-0.12,95%CI -0.41至0.18)。
  • 长期阿片类治疗定义为连续四个季度每季度至少60天阿片类处方,归属于主要阿片类处方医生。

适用人群与场景

  • 接受长期阿片类治疗、其处方医生停止提供门诊患者诊疗或退出劳动力市场(如退休或死亡)的美国Medicare受益人(n=48079)。
  • 倾向性评分匹配的接受长期阿片类治疗、处方医生未退出劳动力市场的美国Medicare受益人(n=48079)。

诊断标准与关键阈值

  • 长期阿片类治疗定义为连续四个季度每季度至少60天阿片类处方,归属于主要阿片类处方医生。

研究设计与关键结果

  • 设计:准实验双重差分研究;设置:2011-18年美国Medicare受益人20%样本;两组各48079例。
  • 主要结局:处方医生退出后一个季度,长期阿片类治疗中止率从每万患者132例升至229例,对照组从97例升至100例(校正差值1.22个百分点,95%CI 1.02至1.42)。
  • 退出后第一季度:自杀未遂校正差值0.05个百分点(95%CI 0.01至0.09),阿片或酒精戒断0.14(95%CI 0.01至0.27),住院或急诊就诊0.04次就诊(95%CI 0.01至0.06),差异在1至2个季度后消退。
  • 退出后四个季度整体:精神卫生危机升高0.39个百分点(95%CI 0.08至0.69),阿片或酒精戒断升高0.31(95%CI 0.014至0.58);药物过量无变化(-0.12,95%CI -0.41至0.18)。
  • 药物过量在退出后第一季度无显著变化。

证据类型、等级与局限

  • 证据类型:准实验双重差分研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在考虑未观察混杂后,长期阿片类治疗中止可能与暂时性健康不良影响相关。
  • 作者认为,处方医生流失与长期阿片类治疗中止及自杀未遂等不良结局的一过性增加相关,但未涉及过量等其他结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To examine the association between prescriber workforce exit, long term opioid treatment discontinuation, and clinical outcomes.

DESIGN: Quasi-experimental difference-in-differences study SETTING: 20% sample of US Medicare beneficiaries, 2011-18.

PARTICIPANTS: People receiving long term opioid treatment whose prescriber stopped providing office based patient care or exited the workforce, as in the case of retirement or death (n=48 079), and people whose prescriber did not exit the workforce (n=48 079).

MAIN OUTCOMES: Discontinuation from long term opioid treatment, drug overdose, mental health crises, admissions to hospital or emergency department visits, and death. Long term opioid treatment was defined as at least 60 days of opioids per quarter for four consecutive quarters, attributed to the plurality opioid prescriber. A difference-in-differences analysis was used to compare individuals who received long term opioid treatment and who had a prescriber leave the workforce to propensity-matched patients on long term opioid treatment who did not lose a prescriber, before and after prescriber exit.

RESULTS: Discontinuation of long term opioid treatment increased from 132 to 229 per 10 000 patients who had prescriber exit from the quarter before to the quarter after exit, compared with 97 to 100 for patients who had a continuation of prescriber (adjusted difference 1.22 percentage points, 95% confidence interval 1.02 to 1.42). In the first quarter after provider exit, when discontinuation rates were highest, a transient but significant elevation was noted between the two groups of patients in suicide attempts (adjusted difference 0.05 percentage points (95% confidence interval 0.01 to 0.09)), opioid or alcohol withdrawal (0.14 (0.01 to 0.27)), and admissions to hospital or emergency department visits (0.04 visits (0.01 to 0.06)). These differences receded after one to two quarters. No significant change in rates of overdose was noted. Across all four quarters after prescriber exit, an increase was reported in the rate of mental health crises (0.39 percentage points (95% confidence interval 0.08 to 0.69)) and opioid or alcohol withdrawal (0.31 (0.014 to 0.58)), but no change was seen for drug overdose (-0.12 (-0.41 to 0.18)).

CONCLUSIONS: The loss of a prescriber was associated with increased occurrences of discontinuation of long term opioid treatment and transient increases in adverse outcomes, such as suicide attempts, but not other outcomes, such as overdoses. Long term opioid treatment discontinuation may be associated with a temporary period of adverse health impacts after accounting for unobserved confounding.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Sabety AH, Neprash HT, Gaye M, et al. Clinical and healthcare use outcomes after cessation of long term opioid treatment due to prescriber workforce exit: quasi-experimental difference-in-differences study. BMJ. 2024. PMID: 38754913. doi:10.1136/bmj-2023-076509

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。